U.S. Pharma Stock News

NasdaqGS:APEI
NasdaqGS:APEIConsumer Services

American Public Education (APEI) Q4 EPS Surge Tests Bullish Margin Expansion Narrative

American Public Education (APEI) closed FY 2025 with Q4 revenue of US$158.3 million and basic EPS of US$0.70, alongside trailing twelve month revenue of US$648.9 million and EPS of US$1.40, setting a clear earnings season marker for investors. The company reported a decline in quarterly revenue from US$164.1 million in Q4 2024 to US$158.3 million in Q4 2025, while basic EPS increased from US$0.65 to US$0.70 over the same period, and those figures now sit against trailing twelve month net...
NasdaqGS:VEON
NasdaqGS:VEONWireless Telecom

VEON (NasdaqGS:VEON) Swings To Q3 Loss Challenging Bullish Earnings Momentum Narrative

VEON (NasdaqGS:VEON) has just reported new figures for FY 2025, with Q3 revenue of US$1.1 billion, a basic EPS loss of US$2, and a net income loss of US$131 million, setting the tone for how the year is shaping up. The company’s quarterly revenue has moved from US$998 million in Q4 2024 to US$1.1 billion in Q3 2025. Over the same period, basic EPS shifted from about US$1.14 in Q4 2024 to US$8.5 in Q2 2025 and then to a loss of US$2 in Q3 2025, leaving investors focused on how the reported...
NasdaqGS:ILMN
NasdaqGS:ILMNLife Sciences

Illumina Alliance Expansion With Regeneron Fuels Multiomic Data Opportunity

Illumina (NasdaqGS:ILMN) and Nashville Biosciences have expanded the Alliance for Genomic Discovery by adding Regeneron Genetics Center as a member. The alliance is launching a new multiomic dataset initiative that includes 312,000 whole genomes and 50,000 paired whole genome and proteomic samples. The effort involves major pharmaceutical firms, including GSK, Amgen and now Regeneron, to support large scale drug discovery and clinical research across diverse diseases. For investors watching...
NYSE:ARL
NYSE:ARLReal Estate

American Realty Investors (ARL) One Off Gain Fuels Profitability And Challenges Bearish Narratives

American Realty Investors (ARL) just wrapped up FY 2025 with Q4 revenue of US$13.0 million and basic EPS of US$0.61, alongside trailing twelve month EPS of US$0.97 and net income of US$15.7 million. Over recent quarters, revenue has ranged from US$11.8 million to US$13.0 million while quarterly EPS has moved between roughly US$0.01 and US$0.61, and the latest period also sits within a year that included a one off gain of US$19.7 million. For investors, that mix of higher earnings levels, a...
NasdaqGS:FIZZ
NasdaqGS:FIZZBeverage

National Beverage (FIZZ) Margin Resilience Challenges Concerns Over Softer Quarterly EPS

National Beverage (FIZZ) has reported a softer third quarter on both the top and bottom line, with Q3 2026 revenue at US$264.6 million and basic EPS of US$0.44. This is set against a trailing twelve month EPS of US$2.01 on US$1.2 billion in revenue. The company has seen quarterly revenue move between US$267.1 million and US$330.5 million over the past six reported periods, while basic EPS has ranged from US$0.42 to US$0.60. This gives investors a clear view of how the latest results fit into...
NYSE:NVRI
NYSE:NVRICommercial Services

Enviri Sustainability Ranking Adds New Angle To Risk And Value Debate

Enviri (NYSE:NVRI) ranked No. 11 on Corporate Knights' inaugural USA 25 Most Sustainable Corporations list. The ranking places Enviri among a select group of U.S. companies recognized for sustainability performance. The list focuses on companies with strong environmental practices and circular economy solutions. For you as an investor, this ranking highlights how Enviri positions its business around environmental services and circular economy offerings, rather than only on short-term...
NasdaqGS:LOCO
NasdaqGS:LOCOHospitality

El Pollo Loco (LOCO) Earnings Growth And 5.4% Margin Test Bearish Narratives

El Pollo Loco Holdings (LOCO) has reported steady third quarter FY 2025 numbers, with revenue of US$121.5 million and EPS of US$0.25, as investors focus on how the chain is handling softer same restaurant sales. The company’s quarterly revenue has moved from US$114.3 million in Q4 2024 to US$119.2 million in Q1 2025, US$125.8 million in Q2 2025, and US$121.5 million in Q3 2025. Over the same period, EPS has tracked from roughly US$0.20 to US$0.19, US$0.24, and US$0.25, providing a clearer...
NasdaqGS:HCAT
NasdaqGS:HCATHealthcare Services

Health Catalyst (HCAT) Losses Swell To US$178 Million Challenging Margin Improvement Narrative

Health Catalyst (HCAT) just wrapped up FY 2025 with Q4 total revenue of US$74.7 million and a basic EPS loss of US$1.28, alongside a full year trailing twelve month revenue base of US$311.1 million and a net loss of US$178.0 million. Over recent quarters the company has seen quarterly revenue move from US$79.4 million in Q1 2025 to US$80.7 million in Q2, US$76.3 million in Q3 and US$74.7 million in Q4. Basic EPS losses ranged from US$0.35 to US$1.28 per share, underscoring a business that is...
NasdaqGS:COST
NasdaqGS:COSTConsumer Retailing

Costco Wholesale (COST) Q2 Same Store Sales Growth Tests Premium Valuation Narrative

Costco Wholesale (COST) has just turned in its Q2 2026 scorecard with revenue of US$69.6b and basic EPS of US$4.58, backed by net income of US$2.0b and 7% same store sales growth. The company has seen quarterly revenue move from US$63.2b in Q3 2025 to US$63.7b in Q2 2025 and then to US$69.6b in Q2 2026, while basic EPS has ranged from US$4.03 to US$5.88 over that stretch, setting the stage for investors to focus on how firmly margins are holding up behind the headline growth. See our full...
NasdaqGM:BNR
NasdaqGM:BNRBiotechs

Burning Rock Biotech (BNR) Loss Reduction Trend Tests Bearish Profitability Concerns

Burning Rock Biotech (NasdaqGM:BNR) has released its latest FY 2025 numbers with third quarter revenue of C¥131.6 million and a basic EPS loss of C¥1.56, alongside net income excluding extra items of a C¥16.8 million loss. The company has seen quarterly revenue range from C¥126.0 million to C¥148.6 million across the last six reported periods, while basic EPS moved between a loss of C¥0.90 and a much steeper loss of C¥10.53 over that time, which underscores the earnings pressure behind the...
NasdaqGS:KYIV
NasdaqGS:KYIVWireless Telecom

Kyivstar Group (NasdaqGS:KYIV) Margin Compression And Q3 Loss Test Bullish Narratives

Kyivstar Group (NasdaqGS:KYIV) has just posted its FY 2025 numbers with Q3 revenue at US$297 million and a net income loss of US$89 million, which translated into a basic EPS loss of US$0.41 for the quarter. The business has seen quarterly revenue move from US$248 million in Q3 2024 to US$297 million in Q3 2025. Over the same period, basic EPS shifted from US$0.40 in Q3 2024 to a loss of US$0.41 in Q3 2025, setting the scene for investors to weigh healthier top line figures against pressure...
NasdaqGM:MPB
NasdaqGM:MPBBanks

Mid Penn Bancorp MPB Net Interest Margin Stability Reinforces Bullish Regional Bank Narratives

Mid Penn Bancorp (MPB) closed out FY 2025 with fourth quarter total revenue of US$62.9 million and basic EPS of US$0.84, alongside net income of US$19.4 million. This capped a twelve month period where revenue reached US$224.6 million and EPS was US$2.59. Over the same trailing twelve month period, earnings grew at 10.3% per year over the past five years and are paired with analyst forecasts that indicate 28.22% annual earnings growth and 16.9% annual revenue growth. Investors can weigh these...
NYSE:HIMS
NYSE:HIMSHealthcare

Hims And Hers Health Weighs Eucalyptus Deal Against Growth And Valuation Risks

Hims & Hers Health (NYSE:HIMS) has agreed to acquire Australian digital health company Eucalyptus, advancing its international expansion beyond the U.S. The deal gives Hims & Hers immediate access to new markets through Eucalyptus’s existing telehealth brands and infrastructure. This move comes as attention has recently centered on the company’s partnerships and legal developments around weight loss treatments. Hims & Hers Health, trading at $24.77, has seen sharp share price swings...
NasdaqGM:LPRO
NasdaqGM:LPROCapital Markets

Open Lending (LPRO) TTM Loss Of US$4.2 Million Tests Bullish Profitability Narratives

Open Lending (LPRO) has just wrapped up FY 2025 with Q4 revenue of US$19.3 million, basic EPS of US$0.01 and net income of US$1.7 million, giving investors a fresh read on how its lending enablement model is translating into the income statement. The company has seen quarterly revenue move from US$23.5 million in Q3 2024 to US$24.4 million in Q1 2025, US$25.3 million in Q2, US$24.2 million in Q3 and US$19.3 million in Q4, while basic EPS has swung between a loss of US$1.21 in Q4 2024 and...
NYSE:KFS
NYSE:KFSInsurance

Kingsway Financial Services (KFS) Premium P/S Multiple Faces Ongoing Losses Narrative

FY 2025 earnings snapshot Kingsway Financial Services (KFS) has wrapped up FY 2025 with fourth quarter revenue of US$38.6 million and a basic EPS loss of US$0.07, alongside net income from ongoing operations of a US$2.1 million loss, keeping the business in the red for the period. The company reported quarterly revenue increasing from US$28.7 million in Q1 2025 to US$38.6 million in Q4, while basic EPS moved within a range from a loss of US$0.13 in Q2 to a loss of US$0.07 in Q4. Over the...
NasdaqGS:AVO
NasdaqGS:AVOFood

Mission Produce (AVO) Margin Compression And Q1 Loss Test Bullish Earnings Narrative

Mission Produce (AVO) opened fiscal Q1 2026 with revenue of US$278.6 million and a small net loss of US$0.7 million, translating to EPS of US$0.01, while its trailing twelve month figures stand at US$1.3 billion in revenue and EPS of about US$0.46. Over recent quarters the company has seen revenue move from US$334.2 million in Q1 2025 to US$380.3 million in Q2, US$357.7 million in Q3 and US$319 million in Q4, with quarterly EPS ranging from roughly US$0.04 to US$0.23 over that stretch. This...
NasdaqCM:KRRO
NasdaqCM:KRROBiotechs

Korro Bio (KRRO) Losses Of US$117.3 Million Test Bullish Narratives On Profitability

Korro Bio (KRRO) has reported its FY 2025 numbers with Q4 revenue of US$1.3 million, a basic EPS loss of US$5.32 and a net income loss of US$50.0 million. Its trailing 12 month figures show revenue of US$6.4 million and a basic EPS loss of US$12.48 tied to a net loss of US$117.3 million. Over recent quarters the company has seen revenue move from US$2.3 million in Q4 FY 2024 to between US$1.1 million and US$2.6 million across FY 2025. This has come alongside quarterly basic EPS losses ranging...
NasdaqGS:ASO
NasdaqGS:ASOSpecialty Retail

Academy Sports Store Openings Highlight Expansion Pace And Valuation Debate

Academy Sports + Outdoors (NasdaqGS:ASO) is opening two new stores in North Canton, Ohio and Muskogee, Oklahoma. The company plans to open these locations as part of a broader rollout of 20 to 25 new stores in fiscal 2026. The new stores are expected to create about 120 local jobs and include charitable initiatives focused on local children. Academy Sports + Outdoors is a full line sporting goods and outdoor retailer. The new locations extend its reach into additional Midwest and South...
NasdaqGS:AOUT
NasdaqGS:AOUTLeisure

American Outdoor Brands (AOUT) EPS Loss Deepens And Tests Profitability Narratives

American Outdoor Brands (AOUT) just posted Q3 2026 results with revenue of US$56.6 million and a basic EPS loss of US$0.32, as net income came in at a loss of US$4.1 million. The company has seen revenue move from US$58.5 million in Q3 2025 to US$56.6 million this quarter, while basic EPS shifted from roughly breakeven at US$0.01 in the prior Q3 to a loss of US$0.32 in Q3 2026. This sets up a quarter where investors are likely to focus on how efficiently that revenue is being converted into...
NasdaqGS:PTEN
NasdaqGS:PTENEnergy Services

A Look At Patterson UTI Energy (PTEN) Valuation After Analyst Upgrades Strong Results And Dividend Increase

Patterson-UTI Energy (PTEN) is back on many investors' screens after a cluster of upbeat analyst reactions to its latest quarterly update, a higher dividend, and fresh optimism around drilling activity. See our latest analysis for Patterson-UTI Energy. The latest move takes Patterson-UTI Energy's share price to $10.29, with a 65.70% 90 day share price return and a 37.33% 1 year total shareholder return, suggesting momentum has been building as quarterly results, dividend growth and drilling...
NasdaqGS:FNKO
NasdaqGS:FNKOLeisure

Funko (FNKO) Posts Breakeven Q4 EPS Keeping Profitability Debate In Focus

Funko (FNKO) has wrapped up FY 2025 with Q4 revenue of US$273.1 million and a small net loss of US$0.2 million, translating to a basic EPS of roughly US$0.00 per share. Trailing 12 month figures show revenue of US$908.2 million and a net loss of US$67.4 million, or a basic EPS loss of US$1.24. The company has seen quarterly revenue range from US$190.7 million to US$273.1 million over the year, with EPS moving between a loss of US$0.74 and a profit of US$0.02. This keeps the focus on how...
NasdaqGS:ARTN.A
NasdaqGS:ARTN.AWater Utilities

Artesian Resources (ARTNA) Margin Strength Supports Bullish Narratives After Q3 FY 2025 Earnings

Artesian Resources (ARTNA) has wrapped up its latest quarter with Q3 FY 2025 revenue of US$30.5 million and basic EPS of US$0.68, alongside trailing 12 month revenue of US$111.8 million and EPS of US$2.19 that frame the broader earnings picture. Over recent quarters the company has seen revenue move from US$25.9 million and EPS of US$0.53 in Q1 FY 2025 to US$28.5 million and EPS of US$0.61 in Q2, before reaching the current Q3 levels. With trailing net profit margins at 20.2% and earnings up...
NasdaqCM:NKTR
NasdaqCM:NKTRPharmaceuticals

Nektar Therapeutics (NKTR) Q3 Losses Narrow To US$35.5 Million Testing Bearish Narratives

Nektar Therapeutics (NKTR) kicked off FY 2025 with a third quarter that paired modest revenue with deep losses, reporting Q3 revenue of US$11.8 million, basic EPS of a US$1.87 loss and a net income loss of US$35.5 million. The company has seen quarterly revenue move from US$23.5 million in Q2 2024 and US$24.1 million in Q3 2024 to US$10.5 million, US$11.2 million and US$11.8 million over the first three quarters of 2025. Basic EPS shifted from a US$3.76 loss and US$2.66 loss in Q2 and Q3 2024...
NasdaqGM:OFLX
NasdaqGM:OFLXMachinery

Omega Flex (OFLX) Margin Decline Challenges Quality Industrial Narrative

Omega Flex (OFLX) just wrapped up FY 2025 with fourth quarter revenue of US$25.2 million and EPS of US$0.34, alongside trailing twelve month revenue of US$98.3 million and EPS of US$1.47 that sit below the prior year’s trailing figures of US$101.7 million and US$1.78 respectively. Over recent periods, quarterly revenue has moved in a tight band between US$23.3 million and US$26.0 million while quarterly EPS has ranged from US$0.35 to US$0.46. This puts the spotlight squarely on how...